42
Medical research, pharmaceutical research and development services in the field of molecular medicine, namely, clinical studies and health care; medical and scientific research, namely, conducting clinical trials featuring the recruitment of study subjects into clinical trials and scientific research consulting for improved clinical trial design; pharmaceutical research in the field of molecular medicine featuring modelling of clinical trials; medical research that analyzes data to identify patterns across patient groups or disease progression; disease management studies, namely, conducting clinical and observational trials to improve disease management; scientific research consulting for improved disease management through clinical and observational trials; scientific research consultancy of health outcomes featuring pharmaco-economic analyses; medical research featuring the identification of disease related biomarkers, the identification and validation of disease characteristics in specific gene biomarkers, protein biomarkers and metabolite biomarkers for use in drug development, molecular diagnostics and improved patient care; licensing of diagnostic methods using identification of disease related biomarkers; medical research featuring the discovery and validation of biomarkers for the association with disease phenotype, namely, validating the clinical relevance of biomarkers and characterizing new biomarkers
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen